Periodic Reporting for period 1 - SeroStrat (The first blood test for the early detection and prognosis of Acute Myeloid Leukaemia)

Acute myeloid leukaemia (AML) accounts for about 25% of all leukaemia in the Western world. Its overall survival rate for 5 years is the lowest of all types of leukaemia (27%): above 60% of AML patients will succumb to the disease. Currently, there is no method for early...